Procter & Gamble Health Limited (PGHL.NS)
INR 5467.25
(0.04%)
INR 5467.25
(0.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.4 Billion | 2.36 Billion | 1.69 Billion | 2.47 Billion | 2.95 Billion | -1.3 Billion |
| Net Income | 2 Billion | 3.14 Billion | 2.53 Billion | 2.33 Billion | 1.69 Billion | 11.37 Billion |
| Depreciation & Amortization | 274 Million | 281 Million | 270.8 Million | 300.4 Million | 192.86 Million | 249.9 Million |
| Deferred income taxes | - | -612.2 Million | - | -541.9 Million | -550.23 Million | - |
| Stock-based compensation | 6.9 Million | 22.4 Million | 90.4 Million | 35.3 Million | 19.7 Million | - |
| Change in working capital | -121.2 Million | -300.3 Million | -473 Million | 525.5 Million | -57.3 Million | -502.6 Million |
| Other non-cash items | 987.5 Million | -156.1 Million | -670.4 Million | -163.5 Million | 1.66 Billion | -12.42 Billion |
| Investing Cash Flow | -194.9 Million | -215 Million | -255.4 Million | -322.7 Million | 1.04 Billion | 12.69 Billion |
| Investments in PPE | -217.3 Million | -424.8 Million | -379.2 Million | -525.8 Million | -232.7 Million | -267.2 Million |
| Acquisitions | 1.4 Million | 47.4 Million | 3.7 Million | 12.1 Million | 3 Million | 10.52 Billion |
| Investment purchases | - | - | - | - | - | -1.05 Billion |
| Sales/Maturities of investments | - | - | - | - | 1.23 Billion | 3.19 Billion |
| Other Investing Activities | 21 Million | 162.4 Million | 120.1 Million | 191 Million | 32.4 Million | 304.2 Million |
| Financing Cash Flow | -4.18 Billion | -984.7 Million | -2.88 Billion | -3.86 Billion | -8.83 Billion | -300.5 Million |
| Debt repayment | -31.2 Million | -46.8 Million | -47.8 Million | -48.5 Million | - | - |
| Dividends payments | -4.14 Billion | -937.9 Million | -2.83 Billion | -3.81 Billion | -8.83 Billion | -249 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -31.2 Million | -46.8 Million | -47.8 Million | -48.5 Million | -1 Billion | -51.5 Million |
| Accounts receivables | 291.7 Million | -329.2 Million | -251.5 Million | 347 Million | -292 Million | -296.2 Million |
| Accounts payables | -716.1 Million | 639.2 Million | -65 Million | 18.1 Million | 354.7 Million | 269.2 Million |
| Inventory | 231.3 Million | -323.9 Million | -20.2 Million | 152.6 Million | -207.5 Million | -280 Million |
| Other working capital | 71.9 Million | -286.4 Million | -136.3 Million | 7.8 Million | 87.5 Million | -222.6 Million |
| Cash at beginning of period | 4.4 Billion | 3.19 Billion | 4.64 Billion | 6.35 Billion | 11.19 Billion | 103.2 Million |
| Cash at end of period | 2.44 Billion | 4.35 Billion | 3.19 Billion | 4.64 Billion | 6.39 Billion | 11.19 Billion |
| Capital Expenditure | -217.3 Million | -424.8 Million | -379.2 Million | -525.8 Million | -232.7 Million | -267.2 Million |
| Effect of forex changes on cash | - | -100 Thousand | - | - | -841.35 Million | - |
| Net cash flow / Change in cash | -1.95 Billion | 1.16 Billion | -1.44 Billion | -1.71 Billion | -4.8 Billion | 11.09 Billion |
| Free Cash Flow | 2.19 Billion | 1.93 Billion | 1.31 Billion | 1.94 Billion | 2.72 Billion | -1.57 Billion |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2 Billion | 167.8 Million | 465.6 Million | 720.7 Million | 655.7 Million | 3.14 Billion |
| Depreciation & Amortization | 274 Million | - | - | - | - | 281 Million |
| Deferred income taxes | - | - | - | - | - | -612.2 Million |
| Stock-based compensation | 6.9 Million | - | - | - | - | 22.4 Million |
| Change in working capital | -121.2 Million | - | - | - | - | -300.3 Million |
| Other non-cash items | 987.5 Million | -167.8 Million | -465.6 Million | -720.7 Million | -655.7 Million | -156.1 Million |
| Investing Cash Flow | -194.9 Million | - | - | - | - | -215 Million |
| Investments in PPE | -217.3 Million | - | - | - | - | -424.8 Million |
| Acquisitions | 1.4 Million | - | - | - | - | 47.4 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 21 Million | - | - | - | - | 162.4 Million |
| Financing Cash Flow | -4.18 Billion | - | - | - | - | -984.7 Million |
| Debt repayment | - | - | - | - | - | -46.8 Million |
| Dividends payments | -4.14 Billion | - | - | - | - | -937.9 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -46.8 Million |
| Accounts receivables | 291.7 Million | - | - | - | - | -329.2 Million |
| Accounts payables | -716.1 Million | - | - | - | - | 639.2 Million |
| Inventory | 231.3 Million | - | - | - | - | -323.9 Million |
| Other working capital | 71.9 Million | - | - | - | - | -286.4 Million |
| Cash at beginning of period | 4.4 Billion | - | - | - | - | 3.19 Billion |
| Cash at end of period | 2.44 Billion | - | - | - | - | 4.35 Billion |
| Capital Expenditure | -217.3 Million | - | - | - | - | -424.8 Million |
| Effect of forex changes on cash | - | - | - | - | - | -100 Thousand |
| Net cash flow / Change in cash | -1.95 Billion | - | - | - | - | 1.16 Billion |
| Free Cash Flow | 2.19 Billion | - | - | - | - | 1.93 Billion |
PDSL
NNGVF
LILM
PIONEEREMB
SB
1685